- Home
- EVGO vs LXRX Comparison
EVGO vs LXRX Comparison
Compare EVGO & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGO
- LXRX
- Stock Information
- Founded
- EVGO 2010
- LXRX 1995
- Country
- EVGO United States
- LXRX United States
- Employees
- EVGO N/A
- LXRX N/A
- Industry
- EVGO Other Specialty Stores
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- EVGO Consumer Discretionary
- LXRX Health Care
- Exchange
- EVGO Nasdaq
- LXRX Nasdaq
- Market Cap
- EVGO 532.0M
- LXRX 428.8M
- IPO Year
- EVGO N/A
- LXRX 2000
- Fundamental
- Price
- EVGO $3.93
- LXRX $1.09
- Analyst Decision
- EVGO Strong Buy
- LXRX Buy
- Analyst Count
- EVGO 10
- LXRX 5
- Target Price
- EVGO $6.10
- LXRX $3.23
- AVG Volume (30 Days)
- EVGO 3.7M
- LXRX 1.9M
- Earning Date
- EVGO 08-05-2025
- LXRX 08-06-2025
- Dividend Yield
- EVGO N/A
- LXRX N/A
- EPS Growth
- EVGO N/A
- LXRX N/A
- EPS
- EVGO N/A
- LXRX N/A
- Revenue
- EVGO $308,365,000.00
- LXRX $58,432,000.00
- Revenue This Year
- EVGO $45.45
- LXRX N/A
- Revenue Next Year
- EVGO $26.93
- LXRX N/A
- P/E Ratio
- EVGO N/A
- LXRX N/A
- Revenue Growth
- EVGO 49.06
- LXRX 1504.83
- 52 Week Low
- EVGO $2.20
- LXRX $0.28
- 52 Week High
- EVGO $9.07
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- EVGO 53.50
- LXRX 47.86
- Support Level
- EVGO $3.80
- LXRX $1.03
- Resistance Level
- EVGO $4.21
- LXRX $1.20
- Average True Range (ATR)
- EVGO 0.20
- LXRX 0.06
- MACD
- EVGO -0.02
- LXRX -0.01
- Stochastic Oscillator
- EVGO 37.21
- LXRX 28.57
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.